...
首页> 外文期刊>Journal of Lipid Research >Differential regulation of cytosolic and peroxisomal bile acid amidation by PPAR alpha activation favors the formation of unconjugated bile acids
【24h】

Differential regulation of cytosolic and peroxisomal bile acid amidation by PPAR alpha activation favors the formation of unconjugated bile acids

机译:PPARα激活对胞浆和过氧化物酶体胆汁酸酰胺化的差异调节有助于形成未结合的胆汁酸

获取原文
获取原文并翻译 | 示例

摘要

In human liver, unconjugated bile acids can be formed by the action of bile acid-CoA thioesterases (BACTEs), whereas bile acid conjugation with taurine or glycine (amidation) is catalyzed by bile acid-CoA:amino acid N-acyltransferases (BACATs). Both pathways exist in peroxisomes and cytosol. Bile acid amidation facilitates biliary excretion, whereas the accumulation of unconjugated bile acids may become hepatotoxic. We hypothesized that the formation of unconjugated and conjugated bile acids from their common substrate bile acid-CoA thioesters by BACTE and BACAT is regulated via the peroxisome proliferator-activated receptor alpha (PPARalpha). Livers from wild-type and PPARalpha-null mice either untreated or treated with the PPARalpha activator WY-14,643 were analyzed for BACTE and BACAT expression. The total liver capacity of taurochenodeoxycholate and taurocholate formation was decreased in WY-14,643-treated wild-type mice by 60% and 40%, respectively, but not in PPARalpha-null mice. Suppression of the peroxisomal BACAT activity was responsible for the decrease in liver capacity, whereas cytosolic BACAT activity was essentially unchanged by the treatment. In both cytosol and peroxisomes, the BACTE activities and protein levels were upregulated 5- to 10-fold by the treatment. These effects caused by WY-14,643 treatment were abolished in PPARalpha-null mice. The results from this study suggest that an increased formation of unconjugated bile acids occurs during PPARalpha activation.
机译:在人肝中,胆汁酸-CoA硫酯酶(BACTE)的作用可形成未结合的胆汁酸,而牛磺酸或甘氨酸的胆汁酸缀合(酰胺化)是通过胆汁酸-CoA:氨基酸N-酰基转移酶(BACAT)催化的。两种途径都存在于过氧化物酶体和胞质溶胶中。胆汁酸酰胺化促进胆汁排泄,而未结合的胆汁酸的积累可能会引起肝毒性。我们假设BACTE和BACAT由它们共同的底物胆汁酸-CoA硫酯形成的未结合的和结合的胆汁酸是通过过氧化物酶体增殖物激活受体α(PPARalpha)来调节的。对未经处理或未用PPARalpha活化剂WY-14,643处理的野生型和PPARalpha-null小鼠的肝脏的BACTE和BACAT表达进行了分析。经WY-14643处理的野生型小鼠的牛磺去氧胆酸和牛磺胆酸的总肝脏容量分别降低了60%和40%,而PPARalpha-null小鼠则没有。过氧化物酶体BACAT活性的抑制是肝容量降低的原因,而胞质BACAT活性在治疗中基本上没有改变。在胞质溶胶和过氧化物酶体中,BACTE活性和蛋白质水平通过该处理上调了5至10倍。由WY-14643治疗引起的这些效应在PPARalpha-null小鼠中被取消。这项研究的结果表明,在PPARalpha激活过程中,未结合的胆汁酸形成增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号